MALVERN, PA — The 2024 Advances in Inflammatory Diseases (AIBD) conference is set to provide groundbreaking educational opportunities and highlight leaders in the field of inflammatory bowel disease (IBD). Scheduled to take place from December 9-11 at the Walt Disney World Dolphin Hotel in Orlando, Florida, this year’s event promises a diverse, cutting-edge program aimed at shaping the future of IBD care.
The three-day event offers clinicians access to real-world case studies, the latest evidence-based management approaches, and insights from renowned experts. It remains the only conference exclusively focused on IBD, drawing hundreds of professionals committed to advancing treatment for Crohn’s disease, ulcerative colitis, and other related conditions.
“Advances in IBD is a transformative journey that seamlessly blends scientific innovation with practical solutions, steering the course for the future of IBD management,” said Dr. Stephen Hanauer, Co-Chair of the conference and Medical Director of the Digestive Health Center at Northwestern University Feinberg School of Medicine.
Enhanced Educational Program
This year’s agenda features over 100 sessions led by 75 expert faculty members, complemented by more than 150 abstracts presenting new research in IBD care. Key additions to the program include five pre-conference workshops on December 8, offering specialized discussions for advanced practice practitioners (APPs), women in IBD leadership, and other segments of the professional community.
The newly introduced APP workshop includes group discussions on preceptorships, underutilized therapies, and opportunities for professional development. Other returning pre-conference workshops include the Building an IBD Center workshop, the fully Spanish PANCCO Symposia, a Fellows Workshop with networking opportunities, and the Women in IBD Leadership Workshop, which will host breakout discussions on challenges and opportunities for women in the field.
The 2024 program has also introduced a new Pharmacy track. This addition allows participants to examine the growing role of pharmacists in IBD care, particularly in the context of dual therapies and medication management resources. Other program tracks include Surgery, Pediatrics, and Nursing, to ensure a comprehensive learning experience for attendees.
Recognizing Excellence Through the Sherman Prize
The AIBD conference continues its tradition of recognizing outstanding contributions to IBD care with the prestigious Sherman Prize. This year’s honorees, to be celebrated on December 10, include three exceptional individuals who have made a lasting impact in their respective fields.
- Dr. Millie D. Long, Professor of Medicine and Interim Division Chief at the University of North Carolina School of Medicine, is recognized for her leadership as a Fellowship Program Director and her groundbreaking work in gastroenterology.
- Dr. Dermot P.B. McGovern, Director of Translational Medicine at Cedar-Sinai Medical Center, receives the honor for his contributions to precision medicine and advancing IBD genetics research.
- Dr. Jordan E. Axelrad, Associate Professor at NYU Grossman School of Medicine and Co-Director of the IBD Center at NYU Langone Health, is noted for his innovative approaches to patient care and his dedication to advancing clinical outcomes.
These esteemed professionals embody the innovative spirit and commitment to excellence that the Sherman Prize represents. Their work drives progress in the fight against IBD and inspires future generations of healthcare providers.
Global Collaboration and Impact
The 2024 AIBD conference is expected to draw over 2,000 participants from around the world, including gastroenterologists, surgeons, nurses, and other healthcare professionals. By uniting experts and practitioners, the event fosters collaboration and innovation aimed at improving care for patients living with IBD.
From its dynamic educational sessions to its recognition of industry leaders, this year’s AIBD conference continues to set the standard for professional engagement and advancements in the field of IBD management.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.